| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58.8M | -5.9% | +57.0% |
| Cost of Revenue | $9.4M | -5.4% | -33.7% |
| R&D Expense | $14.9M | +35.7% | +76.1% |
| SG&A Expense | $29.1M | +9.6% | +9.7% |
| Operating Income | $4.4M | -68.4% | +135.6% |
| Pre-tax Income | $1.2M | +367.6% | +105.8% |
| Income Tax | $615K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $166.4M | +21.2% | +389.3% |
| Accounts Receivable | $66.2M | -9.0% | +105.9% |
| Inventory | $18.6M | +11.6% | -9.0% |
| Current Assets | $258.3M | +10.1% | +158.0% |
| Total Assets | $364.2M | +5.4% | +75.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $36.9M | — | — |
| Capital Expenditures | $221K | — | — |
| Investing Cash Flow | -$49K | — | — |
| Financing Cash Flow | $77.8M | — | — |
| Free Cash Flow | $36.6M | — | — |
| — |
| — |
| Net Income | $540K | +118.6% | +102.7% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| $133.4M |
| +12.4% |
| +103.0% |
| Long-term Debt | $47.6M | +1.2% | +24.2% |
| Total Liabilities | $322.6M | +2.0% | +25.2% |
| Stockholders' Equity | $41.6M | +42.3% | +182.5% |